Universal HealthcareBy NextBestFit

Central coverage decisions can feel like rationing

When one public body decides which treatments are covered or worth their price, every 'no' becomes a national controversy, and patients have no other insurer to turn to.

Evidence

  • NICE in the UK applies cost-per-QALY thresholds and has faced public disputes over declined drugs.

Who's affected

Who is hurt
Who gains while it lasts

Under your mix of paths

Paths that create or worsen it
Paths that fix or soften it
Using your saved plan. 0 paths picked.Edit all picks
Root causes
  • Finite budget with one decision-maker

Open questions

  • How should coverage decisions be made, appealed, and balanced against cost?

Caused or worsened by these paths

This problem only matters if one of these paths is chosen.

Single public payer for everyoneTens of millions of people have no coverageChosen

One public body decides what is covered for everyone, so each 'no' applies nationwide.

Public coverage rules with clinician-led reviewClaim denialsChosen

Public coverage decisions move refusals from individual claims to program-wide rules.

National negotiation for all drugsBrand-name drug prices far above production costChosen

A national negotiating body uses value assessments as benchmarks for drug prices, placing those assessments within a national decision process.

Value-based prices that reward real innovationR&D is funded by high prices, which ties innovation to unaffordabilityChosen

Drug pricing depends on assessments of added benefit, with disputes over how that value should be measured.

Evidence-based coverage decisionsLow-value care and overtreatmentChosen

A public body deciding which services to stop covering can generate controversy over coverage decisions.

Accept somewhat slower adoptionSlower access to new drugs and technologyRejected

Coverage assessment delays some new treatments while avoiding payment for unproven drugs.

Solution paths (3)

Open a path for what it fixes, what it creates or worsens, who gains and who loses, precedents, and how it connects to other paths. See all paths as a decision tree.

An arm's-length agency evaluates evidence and cost in public meetings with patient representatives, publishes reasons, and allows appeals and reconsideration when new evidence appears.

  • +Central coverage decisions can feel like rationing
  • −Takes years, or money up front, before it pays off

Ban cost-per-QALY thresholds; cover any treatment shown to work and control cost through price negotiation instead.

  • +Central coverage decisions can feel like rationing
  • +Claim denials
  • −Chronic underfunding by government budgets
  • −Raises spending or loosens control over it

Clinicians can request coverage for individual patients outside the standard list, decided within days by a clinical panel.

  • +Central coverage decisions can feel like rationing
  • −Racial, income, and geographic disparities